Landefeld C C, Fomenou L A, Ateba F, Msellati P
a Cleveland Clinic Lerner College of Medicine , Case Western Reserve University , Cleveland , OH , USA.
b Département d'Anthropologie , Université de Yaoundé I , Yaoundé , Cameroon.
AIDS Care. 2018 Jan;30(1):116-120. doi: 10.1080/09540121.2017.1390540. Epub 2017 Oct 16.
Most HIV-infected children in Sub-Saharan Africa are born where programs for the prevention of mother-to-child transmission of HIV (PMTCT) exist but are not universally operational. The expansion of PMTCT programs in Cameroon was among the largest in francophone Africa, but despite highly variable estimates of PMTCT uptake (ranging from 20% to 66%), it is clear that not enough HIV-infected pregnant Cameroonian women benefit from treatment to prevent HIV transmission to their children. The reasons why HIV-infected women in Cameroon do not use treatments to prevent this transmission remain partially unidentified. We conducted a qualitative study of the therapeutic itineraries (treatments taken and motivations) followed by HIV-infected pregnant women in Cameroon to understand the barriers to accessing high-quality PMTCT care. Here we construct the therapeutic itinerary for HIV-infected pregnant women, and identify the barriers at each step. Lack of financial independence, personal support, and empowering information were the primary obstacles at multiple steps.
撒哈拉以南非洲地区的大多数感染艾滋病毒的儿童出生在设有预防母婴传播艾滋病毒（PMTCT）项目的地方，但这些项目并非普遍运行。喀麦隆的PMTCT项目扩展规模在非洲法语国家中是最大的之一，然而，尽管对PMTCT项目的接受率估计差异很大（从20%到66%不等），但显然没有足够多感染艾滋病毒的喀麦隆孕妇从预防艾滋病毒传播给孩子的治疗中受益。喀麦隆感染艾滋病毒的妇女不采用预防传播治疗的原因仍部分不明。我们对喀麦隆感染艾滋病毒的孕妇所采取的治疗行程（接受的治疗和动机）进行了定性研究，以了解获得高质量PMTCT护理的障碍。在此，我们构建了感染艾滋病毒孕妇的治疗行程，并确定了每一步的障碍。缺乏经济独立、个人支持和赋权信息是多个步骤中的主要障碍。
